Core Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,078
| Closed | -$95K | – | 216 |
|
|
2022
Q1 | $95K | Buy |
2,078
+232
| +13% | +$10.6K | 0.05% | 56 |
|
|
2021
Q4 | $113K | Buy |
1,846
+211
| +13% | +$12.9K | 0.07% | 55 |
|
|
2021
Q3 | $122K | Buy |
1,635
+117
| +8% | +$8.73K | 0.08% | 55 |
|
|
2021
Q2 | $140K | Sell |
1,518
-1,013
| -40% | -$93.4K | 0.09% | 44 |
|
|
2021
Q1 | $225K | Buy |
2,531
+1,013
| +67% | +$90.1K | 0.2% | 30 |
|
|
2020
Q4 | $142K | Buy |
1,518
+43
| +3% | +$4.02K | 0.13% | 34 |
|
|
2020
Q3 | $94K | Hold |
1,475
| – | – | 0.09% | 39 |
|
|
2020
Q2 | $77K | Buy |
+1,475
| New | +$77K | 0.07% | 48 |
|